Crystal Structure of the Human BRD2 Bromodomain

• Published in: The Journal of biological chemistry 2007-02, Vol.282 (6), p.4193-4201
• Main Authors: Nakamura, Yoshihiro, Umehara, Takashi, Nakano, Kazumi, Jang, Moon Kyoo, Shirouzu, Mikako, Morita, Satoshi, Uda-Tochio, Hiroko, Hamana, Hiroaki, Terada, Takaho, Adachi, Naruhiko, Matsumoto, Takehisa, Tanaka, Akiko, Horikoshi, Masami, Ozato, Keiko, Padmanabhan, Balasundaram, Yokoyama, Shigeyuki
• Format: Article
• Language: English
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M605971200

The BET (bromodomains and extra terminal domain) family proteins recognize acetylated chromatin through their bromodomain and act as transcriptional activators. One of the BET proteins, BRD2, associates with the transcription factor E2F, the mediator components CDK8 and TRAP220, and RNA polymerase II, as well as with acetylated chromatin during mitosis. BRD2 contains two bromodomains (BD1 and BD2), which are considered to be responsible for binding to acetylated chromatin. The BRD2 protein specifically recognizes the histone H4 tail acetylated at Lys12. Here, we report the crystal structure of the N-terminal bromodomain (BD1, residues 74-194) of human BRD2. Strikingly, the BRD2 BD1 protein forms an intact dimer in the crystal. This is the first observation of a homodimer among the known bromodomain structures, through the buried hydrophobic core region at the interface. Biochemical studies also demonstrated BRD2 BD1 dimer formation in solution. The two acetyllysine-binding pockets and a negatively charged secondary binding pocket, produced at the dimer interface in BRD2 BD1, may be the unique features that allow BRD2 BD1 to selectively bind to the acetylated H4 tail.